Dr. Ansuman Satpathy on Single-Cell Epigenome Technologies for Precision Immune Profiling

The Michelson Medical Research Foundation and the Human Immunome Project (formerly Human Vaccines Project) hosted the first Annual Conference on the Future of Vaccine Development on June 27, 2018, at the USC Michelson Center for Convergent Bioscience.

The conference brought together leading scientists and researchers from around the world to discuss the latest advances in vaccines and to explore new ways to accelerate the development of vaccines against some of the world's most threatening diseases.

Michelson Prize Recipient: Dr. Ansuman Satpathy

Dr. Ansuman Satpathy is a Michelson Prize recipient and an Instructor in the Department of Pathology and a Postdoctoral Fellow in the Department of Genetics at Stanford University School of Medicine. His research focuses on developing and applying genome-scale technologies to study fundamental properties of the immune system in health, infection, and cancer.

Single-Cell Epigenome Technologies for Precision Immune Profiling

In this video clip, Dr. Satpathy discusses his work on single-cell epigenome technologies for precision immune profiling. He explains how these technologies can be used to study the immune system at a single-cell level, and improve our understanding of diseases to develop new treatments.

Learn more about his medical research: https://profiles.stanford.edu/ansuman-satpathy.